 
 


EXTRA takes a unique approach to the interpretation of exercise 
    test results, using a combination of scores rather than a single score. Using 
    simple clinical and exercise test variables and scores improves the predictive 
    accuracy of detecting the presence and severity of coronary artery disease 
    far beyond the use of standard ECG criteria. In addition, the unique approach 
    appears to be unaffected by disease prevalence, missing data, definition variances 
    and even by angiographic criterion.
    
    The outcomes are then stratified into low, intermediate and high risk for 
    any coronary artery disease. Given that the patients in the intermediate group 
    would be sent for further testing and would eventually be correctly classified, 
    this approach has a sensitivity and specificity for any CAD of 85% and 92%, 
    respectively, and a sensitivity and specificity for predicting severe CAD 
    of 81% and 91%, respectively. Overall, a predictive accuracy of 88% is obtained 
    by using EXTRA and this scoring strategy. These are results typically seen 
    only with more expensive imaging modalities such as Stress Echo, Thallium/SPECT 
    testing and Electron-Beam CT.
| Test Modality | Any CAD Sensitivity | Any CAD Specificity | Predictive Accuracy | 
|---|---|---|---|
| Standard Exercise ECG | 68% | 77% | 73% | 
| Thallium Scintillography | 85% | 85% | 85% | 
| SPECT | 88% | 72% | 80% | 
| Adenosine SPECT | 89% | 80% | 85% | 
| Exercise ECHO | 84% | 75% | 80% | 
| Dobutamine ECHO | 88% | 84% | 86% | 
| Dobutamine Scintillography | 88% | 74% | 81% | 
| EBCT | 60% | 70% | 65% | 
| EXTRA + Score Strategy | 85% | 92% | 88% | 
This approach effectively limits the usage of these more expensive imaging modalities to one-third of patients and excludes the need for cardiac catheterization in another one-third of the patients. Also, these results could frequently prevent the need for cardiac catheterization.
Corporate 
    Headquarters
    
    Sunnyside Biomedical LLC
    P.O. Box 1171
    Mountain View, CA 94042
    Ph: 650-331-1897
    Fax: 310-526-7775 
    
    Request 
    additional information